COMMUNIQUÉS West-GlobeNewswire

Preliminary Financial Figures for the 2024 Fiscal Year
06/01/2025
January 6, 2025 Announcement no. 01 Preliminary Financial Figures for the 2024 Fiscal Year COPENHAGEN, DENMARK, January 6, 2025, (GLOBE NEWSWIRE) – BioPorto A/S CVR-no. 17500317 (BioPorto or Company) (CPH:BIOPOR), an in [...]
UPDATE - Basecamp Research Appoints John Finn, Ph.D., as CSO, Expands Internationally with U.S. Lab and Offices, and Builds One of Europe's Largest Industrial Supercomputers with NVIDIA Accelerated Computing
06/01/2025
Finn, an industry leader in the field of cell and gene therapy, will lead company’s efforts to advance groundbreaking approaches to programmable genetic medicines Office and lab in Kendall Square (Cambridge, Mass.) to [...]
Ose Immunotherapeutics : Informations relatives au nombre total de droits de vote et d’actions composant le capital
06/01/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 6 janvier 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
06/01/2025
Saint Herblain (France), January 6, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that members of its management team will meet one-on-one with existing shareholders [...]
Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference
06/01/2025
Saint Herblain (France), le 6 janvier 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que des membres de son équipe dirigeante rencontreront des [...]
EUROAPI welcomes the French Minister for Health and Access to Healthcare Yannick Neuder and the French Minister for Industry and Energy Marc Ferracci to its Puy-de-Dôme site
06/01/2025
Press Release A tour of Vertolaye manufacturing and storage facilities highlighted EUROAPI’s long-term commitment to health sovereignty Paris and Vertolaye - January 6, 2025 – The French Minister for Health and Access [...]
EUROAPI accueille le ministre de la Santé et de l’Accès aux soins Yannick Neuder et le ministre de l’Industrie et de ’Energie Marc Ferracci sur son site du Puy-de-Dôme
06/01/2025
Communiqué de presse La visite des unités de fabrication et de stockage de Vertolaye a permis de rappeler l’engagement de long terme d’EUROAPI en faveur de la souveraineté sanitaire Paris et Vertolaye – Le 6 janvier [...]
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
06/01/2025
Press Release – No. 1 / 2025 Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th Copenhagen, Denmark, January 6, 2025 – Zealand Pharma A/S (CVR-no. 20045078), a biotechnology [...]
Buckingham Psychiatry Unveils a New Way to Get Help via an Online Patient Portal
06/01/2025
Dr. Jacob Buinewicz, a Philadelphia-area general psychiatrist, added a patient portal to his new website in late 2024 DOYLESTOWN, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) -- As a general psychiatrist serving the Philadelphia [...]
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
06/01/2025
Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and decades of longitudinal drug response data Data provides a critical pathway to [...]
Predictive Oncology Announces Agreement to be Acquired by Renovaro
06/01/2025
- Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple cancer indications – - Deal terms align shareholders’ interest, augment [...]
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
04/01/2025
IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) [...]
Oculis Publishes Notification of Major Changes in Voting Rights
04/01/2025
ZUG, Switzerland, Jan. 04, 2025 (GLOBE NEWSWIRE) -- Attached is a Notification of Major Changes in Voting Rights, in relation to Brunnur vaxtarsjóður slhf‘s distribution of its shares in Oculis Holding AG to Brunnur [...]
ARCPOINT CLOSES SALE OF OWNERSHIP STAKE IN NON-CORE ASSET
04/01/2025
Greenville, South Carolina , Jan. 03, 2025 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) reports that it has now completed the sale of its 68% share ownership interest in Achieve [...]
Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/01/2025
Carlsbad, CA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel [...]
PharmaTher Announces Grant of Stock Options
03/01/2025
TORONTO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announces that it has granted a total of 800,000 stock [...]
BriaCell Announces Proposed Effective Date of Share Consolidation
03/01/2025
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“ BriaCell ” or the “ Company ”), a clinical-stage biotechnology company that [...]
BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025
03/01/2025
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“ BriaCell ” or the “ Company ”), a clinical-stage biotechnology company that [...]
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/01/2025
LAKE FOREST, Ill., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]

Pages